Citations

Showing 10 of 108083 citations.

Evaluation of Intratumoral and Intertumoral Heterogeneity of MET Protein Expression in Gastric Cancer
Choi, Jiwoon , Lee, Hee Eun , Lee, Hye Seung , Kim, Min A, Kim, Woo Ho , Han, Nayoung , Kim, Min A

Mayo Clinic

Applied Immunohistochemistry & Molecular Morphology | September 29, 2017 | Volume: 26 | Issue: 7 | Pages: 445-453

10.1097/pai.0000000000000448 | PMID 28968267 Get It

Tumor heterogeneity of a target molecule could contribute to failure of the targeted therapy. We investigated the heterogeneity of MET expression within same primary gastric cancer (GC) and between primary and corresponding secondary GC lesions using immunohistochemistry (IHC). Intratumoral heterogeneity was defined as discordant MET status among 3 tissue microarray cores (3 different areas of same tumor). IHC 3+ was considered positive for MET overexpression. MET overexpression was observed in 2.7% (50/1869) of all examined cores and 5.3% (33/623) of primary GCs. When we compared MET IHC results between 3 cores from each tumor, intratumoral heterogeneity was identified (65.0% in total 623 cases; 84.4% in 480 cases with any staining intensity; 84.9% in 251 cases with moderate to strong intensity; 90.9% in 33 cases with strong intensity). Of 33 MET-overexpressed GCs, the average proportion of strongly stained area was 19.6% in the whole sections. Of 269 cases with primary GC and regional lymph node metastasis, 17 (6.3%) showed MET positivity in which 9 (52.9%) were discordant (negative conversion). In 123 cases with primary and corresponding local recurrent/distant metastatic GC, 3 (2.4%) showed MET positivity in which 2 (66.7%) were discordant (positive conversion). In the survival analysis, MET IHC 3+ in lymph node metastases was an independent negative prognostic factor for overall survival. We found that MET overexpression is uncommon and highly heterogeneous in GC. This severe heterogeneity of MET status should be considered in tissue sampling and development of biomarkers for anti-MET therapy.
Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era
Thanarajasingam, Gita , Maurer, Matthew J. , Farooq, Umar , Johnston, Patrick B., Thompson, Carrie A. , Bennani, Nabila Nora, Ansell, Stephen M. , Porrata, Luis F. , Macon, William R. , Syrbu, Sergei , Link, Brian K. , Nowakowski, Grzegorz S. , Bennani, Nabila N, Maurer, Matthew , Link, Brian K , Farooq, Umar , Johnston, Patrick B. , Cerhan, James R. , Habermann, Thomas M. , Witzig, Thomas E. , Syrbu, Sergei

Mayo Clinic

British Journal of Haematology | September 29, 2017 | Volume: 183 | Issue: 1 | Pages: 149-152

10.1111/bjh.14922 | PMID 28961306 Get It

The Currency of Science
Vella, Adrian

Mayo Clinic

Metabolic Syndrome and Related Disorders | September 29, 2017 | Volume: 15 | Issue: 8 | Pages: 385-386

10.1089/met.2017.0130 | PMID 28922059 Get It

Hepatobiliary and Pancreatic: Hepatic necrobiotic xanthogranuloma
Nguyen, Ba D.

Mayo Clinic

Journal of Gastroenterology and Hepatology | September 29, 2017 | Volume: 32 | Issue: 10 | Pages: 1667-1667

10.1111/jgh.13858 | PMID 28948701 Get It

Patient characteristics of smokers undergoing lumbar spine surgery: an analysis from the Quality Outcomes Database
Asher, Anthony L. , Devin, Clinton J. , McCutcheon, Brandon A., Chotai, Silky , Archer, Kristin R. , Nian, Hui , McGirt, Matthew J., Mummaneni, Praveen V. , Shaffrey, Christopher I. , Foley, Kevin T. , Glassman, Steven D. , Bydon, Mohamad , McCutcheon, Brandon, Harrell, Frank E.

Mayo Clinic

Journal of Neurosurgery: Spine | September 29, 2017 | Volume: 27 | Issue: 6 | Pages: 661-669

10.3171/2017.4.spine16984 | PMID 28960162 Get It

OBJECTIVEIn this analysis the authors compare the characteristics of smokers to nonsmokers using demographic, socioeconomic, and comorbidity variables. They also investigate which of these characteristics are most strongly associated with smoking status. Finally, the authors investigate whether the association between known patient risk factors and disability outcome is differentially modified by patient smoking status for those who have undergone surgery for lumbar degeneration.METHODSA total of 7547 patients undergoing degenerative lumbar surgery were entered into a prospective multicenter registry (Quality Outcomes Database [QOD]). A retrospective analysis of the prospectively collected data was conducted. Patients were dichotomized as smokers (current smokers) and nonsmokers. Multivariable logistic regression analysis fitted for patient smoking status and subsequent measurement of variable importance was performed to identify the strongest patient characteristics associated with smoking status. Multivariable linear regression models fitted for 12-month Oswestry Disability Index (ODI) scores in subsets of smokers and nonsmokers was performed to investigate whether differential effects of risk factors by smoking status might be present.RESULTSIn total, 18% (n = 1365) of patients were smokers and 82% (n = 6182) were nonsmokers. In a multivariable logistic regression analysis, the factors significantly associated with patients’ smoking status were sex (p < 0.0001), age (p < 0.0001), body mass index (p < 0.0001), educational status (p < 0.0001), insurance status (p < 0.001), and employment/occupation (p = 0.0024). Patients with diabetes had lowers odds of being a smoker (p = 0.0008), while patients with coronary artery disease had greater odds of being a smoker (p = 0.044). Patients’ propensity for smoking was also significantly associated with higher American Society of Anesthesiologists (ASA) class (p < 0.0001), anterior-alone surgical approach (p = 0.018), greater number of levels (p = 0.0246), decompression only (p = 0.0001), and higher baseline ODI score (p < 0.0001). In a multivariable proportional odds logistic regression model, the adjusted odds ratio of risk factors and direction of improvement in 12-month ODI scores remained similar between the subsets of smokers and nonsmokers.CONCLUSIONSUsing a large, national, multiinstitutional registry, the authors described the profile of patients who undergo lumbar spine surgery and its association with their smoking status. Compared with nonsmokers, smokers were younger, male, nondiabetic, nonobese patients presenting with leg pain more so than back pain, with higher ASA classes, higher disability, less education, more likely to be unemployed, and with Medicaid/uninsured insurance status. Smoking status did not affect the association between these risk factors and 12-month ODI outcome, suggesting that interventions for modifiable risk factors are equally efficacious between smokers and nonsmokers.
Pure arterial malformations
Brinjikji, Waleed , Cloft, Harry J. , Flemming, Kelly D. , Comelli, Simone , Lanzino, Giuseppe , Flemming, Kelly D

Mayo Clinic

Journal of Neurosurgery | September 29, 2017 | Volume: 129 | Issue: 1 | Pages: 91-99

10.3171/2017.2.jns1744 | PMID 28960150 Get It

OBJECTIVEOver the last half century, there have been isolated case reports of purely arterial malformations. In this study, the authors report a consecutive series of patients with pure arterial malformations, emphasizing the clinical and radiological features of these lesions.METHODSPure arterial malformations were defined as dilated, overlapping, and tortuous arteries with a coil-like appearance and/or a mass of arterial loops without any associated venous component. Demographic characteristics of the patients, cardiovascular risk factors, presentation, radiological characteristics, and follow-up data were collected. Primary outcomes were new neurological symptoms including disability, stroke, and hemorrhage.RESULTSTwelve patients meeting the criteria were identified. Ten patients were female (83.3%) and 2 were male (16.6%). Their mean age at diagnosis was 26.2 ± 11.6 years. The most common imaging indication was headache (7 patients [58.3%]). In 3 cases the pure arterial malformation involved the anterior cerebral arteries (25.0%); in 4 cases the posterior communicating artery/posterior cerebral artery (33.3%); in 2 cases the middle cerebral artery (16.6%); and in 1 case each, the superior cerebellar artery, basilar artery/anterior inferior cerebellar artery, and posterior inferior cerebellar artery. The mean maximum diameter of the malformations was 7.2 ± 5.0 mm (range 3–16 mm). Four lesions had focal aneurysms associated with the pure arterial malformation, and 5 were partially calcified. In no cases was there associated intracranial hemorrhage or infarction. One patient underwent treatment for the pure arterial malformation. All 12 patients had follow-up (mean 29 months, median 19 months), and there were no cases of disability, stroke, or hemorrhage.CONCLUSIONSPure arterial malformations are rare lesions that are often detected incidentally and probably have a benign natural history. These lesions can affect any of the intracranial arteries and are likely best managed conservatively.
A Potential Novel Mechanism for Vagus Nerve Stimulator-Related Central Sleep Apnea
Forde, Inga, Kotagal, Suresh , Forde, Inga C, Kolla, Bhanu Prakash , Mansukhani, Meghna P.

Mayo Clinic

Children | September 29, 2017 | Volume: 4 | Issue: 10 | Pages: 86

10.3390/children4100086 | PMID 28961186 Get It

The treatment of epilepsy with vagus nerve stimulation can inadvertently cause obstructive and central sleep apnea (CSA). The mechanism for CSA seen in patients with a vagus nerve stimulator (VNS) is not fully known. We describe the case of a 13-year-old girl in whom VNS activation induced tachypnea and post-hyperventilation central apnea. Following adjustment of VNS settings, the post-hyperventilation CSA resolved. Polysomnography may assist with management when patients with epilepsy develop sleep disruption after VNS placement.
Endothelium-specific amyloid precursor protein deficiency causes endothelial dysfunction in cerebral arteries
d’Uscio, Livius V. , He, Tongrong , Santhanam, Anantha V., Katušić, Zvonimir S. , Santhanam, Anantha Vijay R.

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | September 29, 2017 | Volume: 38 | Issue: 10 | Pages: 1715-1726

10.1177/0271678x17735418 | PMID 28959912 Get It

The exact physiological function of amyloid-β precursor protein (APP) in endothelial cells is unknown. Endothelium-specific APP-deficient (eAPP −/− ) mice were created to gain new insights into the role of APP in the control of vascular endothelial function. Endothelium-dependent relaxations to acetylcholine were significantly impaired in basilar arteries of global APP knockout (APP −/− ) and eAPP −/− mice ( P < 0.05). In contrast, endothelium-independent relaxations to nitric oxide (NO)-donor diethylamine-NONOate were unchanged. Western blot analysis revealed that protein expression of endothelial nitric oxide synthase (eNOS) was significantly downregulated in large cerebral arteries of APP −/− mice and eAPP −/− mice as compared to respective wild-type littermates ( P < 0.05). Furthermore, basal levels of cyclic guanosine monophosphate (cGMP) were also significantly reduced in large cerebral arteries of APP-deficient mice ( P < 0.05). In contrast, protein expression of prostacyclin synthase as well as levels of cyclic adenosine monophosphate (cAMP) was not affected by genetic inactivation of APP in endothelial cells. By using siRNA to knockdown APP in cultured human brain microvascular endothelial cells we also found a significant downregulation of eNOS mRNA and protein expressions in APP-deficient endothelium ( P < 0.05). These findings indicate that under physiological conditions, expression of APP in cerebral vascular endothelium plays an important protective function by maintaining constitutive expression of eNOS .
Commentary on Reactive Eccrine Syringofibroadenoma Associated With Basal Cell Carcinoma
Lopez, Jonathan J.

Mayo Clinic

Dermatologic Surgery | September 29, 2017 | Volume: 44 | Issue: 5 | Pages: 740-741

10.1097/dss.0000000000001320 | PMID 28961639 Get It

Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer
Pal, Krishnendu , Al-suraih, Farah, González-Rodríguez, Roberto , Dutta, Shamit K., Wang, Enfeng , Kwak, H. Shaun , Caulfield, Thomas R. , Coffer, Jeffery L. , Bhattacharya, Santanu , Caulfield, Thomas R , Pal, Krishnendu , Bhattacharya, Santanu

Mayo Clinic

Nanoscale | September 29, 2017 | Volume: 9 | Issue: 40 | Pages: 15622-15634

10.1039/c7nr03172f | PMID 28991294 Get It

Tumor-selective uptake of plectin-1 targeting peptide-modified gold nanoparticles ameliorates targeted delivery of gemcitabine in pancreatic ductal adenocarcinoma.